Literature DB >> 33211406

Proteasome interaction with ubiquitinated substrates: from mechanisms to therapies.

Xiang Chen1, Zaw Min Htet2, Erika López-Alfonzo2, Andreas Martin2,3, Kylie J Walters1.   

Abstract

The 26S proteasome is responsible for regulated proteolysis in eukaryotic cells. Its substrates are diverse in structure, function, sequence length, and amino acid composition, and are targeted to the proteasome by post-translational modification with ubiquitin. Ubiquitination occurs through a complex enzymatic cascade and can also signal for other cellular events, unrelated to proteasome-catalyzed degradation. Like other post-translational protein modifications, ubiquitination is reversible, with ubiquitin chain hydrolysis catalyzed by the action of deubiquitinating enzymes (DUBs), ~ 90 of which exist in humans and allow for temporal events and dynamic ubiquitin-chain remodeling. DUBs have been known for decades to be an integral part of the proteasome, as deubiquitination is coupled to substrate unfolding and translocation into the internal degradation chamber. Moreover, the proteasome also binds several ubiquitinating enzymes and shuttle factors that recruit ubiquitinated substrates. The role of this intricate machinery and how ubiquitinated substrates interact with proteasomes remains an area of active investigation. Here, we review what has been learned about the mechanisms used by the proteasome to bind ubiquitinated substrates, substrate shuttle factors, ubiquitination machinery, and DUBs. We also discuss many open questions that require further study or the development of innovative approaches to be answered. Finally, we address the promise of expanded therapeutic targeting that could benefit from such new discoveries.
© 2020 Federation of European Biochemical Societies.

Entities:  

Keywords:  PROTAC; deubiquitination; proteasome; ubiquitin; ubiquitination

Mesh:

Substances:

Year:  2020        PMID: 33211406      PMCID: PMC8131406          DOI: 10.1111/febs.15638

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.622


  182 in total

1.  Proteasome subunit Rpn1 binds ubiquitin-like protein domains.

Authors:  Suzanne Elsasser; Rayappa R Gali; Martin Schwickart; Christopher N Larsen; David S Leggett; Britta Müller; Matthew T Feng; Fabian Tübing; Gunnar A G Dittmar; Daniel Finley
Journal:  Nat Cell Biol       Date:  2002-09       Impact factor: 28.824

2.  Molecular architecture of the 26S proteasome holocomplex determined by an integrative approach.

Authors:  Keren Lasker; Friedrich Förster; Stefan Bohn; Thomas Walzthoeni; Elizabeth Villa; Pia Unverdorben; Florian Beck; Ruedi Aebersold; Andrej Sali; Wolfgang Baumeister
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-23       Impact factor: 11.205

3.  Structures of Rpn1 T1:Rad23 and hRpn13:hPLIC2 Reveal Distinct Binding Mechanisms between Substrate Receptors and Shuttle Factors of the Proteasome.

Authors:  Xiang Chen; Leah Randles; Ke Shi; Sergey G Tarasov; Hideki Aihara; Kylie J Walters
Journal:  Structure       Date:  2016-07-07       Impact factor: 5.006

4.  Multiple associated proteins regulate proteasome structure and function.

Authors:  David S Leggett; John Hanna; Anna Borodovsky; Bernat Crosas; Marion Schmidt; Rohan T Baker; Thomas Walz; Hidde Ploegh; Daniel Finley
Journal:  Mol Cell       Date:  2002-09       Impact factor: 17.970

5.  Ubiquitinated proteins activate the proteasomal ATPases by binding to Usp14 or Uch37 homologs.

Authors:  Andreas Peth; Nikolay Kukushkin; Marc Bossé; Alfred L Goldberg
Journal:  J Biol Chem       Date:  2013-01-22       Impact factor: 5.157

6.  A bis-benzylidine piperidone targeting proteasome ubiquitin receptor RPN13/ADRM1 as a therapy for cancer.

Authors:  Ravi K Anchoori; Balasubramanyam Karanam; Shiwen Peng; Joshua W Wang; Rosie Jiang; Toshihiko Tanno; Robert Z Orlowski; William Matsui; Ming Zhao; Michelle A Rudek; Chien-fu Hung; Xiang Chen; Kylie J Walters; Richard B S Roden
Journal:  Cancer Cell       Date:  2013-12-09       Impact factor: 31.743

7.  Structural basis for the activation and inhibition of the UCH37 deubiquitylase.

Authors:  Ryan T Vander Linden; Casey W Hemmis; Benjamin Schmitt; Ada Ndoja; Frank G Whitby; Howard Robinson; Robert E Cohen; Tingting Yao; Christopher P Hill
Journal:  Mol Cell       Date:  2015-02-19       Impact factor: 17.970

8.  UBL/BAG-domain co-chaperones cause cellular stress upon overexpression through constitutive activation of Hsf1.

Authors:  Esben G Poulsen; Caroline Kampmeyer; Franziska Kriegenburg; Jens V Johansen; Kay Hofmann; Christian Holmberg; Rasmus Hartmann-Petersen
Journal:  Cell Stress Chaperones       Date:  2016-12-14       Impact factor: 3.667

9.  Cryo-EM Reveals Unanchored M1-Ubiquitin Chain Binding at hRpn11 of the 26S Proteasome.

Authors:  Xiang Chen; Zachary Dorris; Dan Shi; Rick K Huang; Htet Khant; Tara Fox; Natalia de Val; Dewight Williams; Ping Zhang; Kylie J Walters
Journal:  Structure       Date:  2020-08-11       Impact factor: 5.006

10.  Covalent Rpn13-Binding Inhibitors for the Treatment of Ovarian Cancer.

Authors:  Ravi K Anchoori; Rosie Jiang; Shiwen Peng; Ruey-Shyang Soong; Aliyah Algethami; Michelle A Rudek; Nicole Anders; Chien-Fu Hung; Xiang Chen; Xiuxiu Lu; Olumide Kayode; Marzena Dyba; Kylie J Walters; Richard B S Roden
Journal:  ACS Omega       Date:  2018-09-27
View more
  8 in total

Review 1.  A second chance for protein targeting/folding: Ubiquitination and deubiquitination of nascent proteins.

Authors:  Jacob A Culver; Xia Li; Matthew Jordan; Malaiyalam Mariappan
Journal:  Bioessays       Date:  2022-03-31       Impact factor: 4.653

Review 2.  Site-specific ubiquitination: Deconstructing the degradation tag.

Authors:  Emma C Carroll; Susan Marqusee
Journal:  Curr Opin Struct Biol       Date:  2022-03-02       Impact factor: 7.786

3.  Structure-guided bifunctional molecules hit a DEUBAD-lacking hRpn13 species upregulated in multiple myeloma.

Authors:  Xiuxiu Lu; Venkata R Sabbasani; Vasty Osei-Amponsa; Christine N Evans; Julianna C King; Sergey G Tarasov; Marzena Dyba; Sudipto Das; King C Chan; Charles D Schwieters; Sulbha Choudhari; Caroline Fromont; Yongmei Zhao; Bao Tran; Xiang Chen; Hiroshi Matsuo; Thorkell Andresson; Raj Chari; Rolf E Swenson; Nadya I Tarasova; Kylie J Walters
Journal:  Nat Commun       Date:  2021-12-16       Impact factor: 14.919

Review 4.  Protein Quality Control at the Mitochondrial Surface.

Authors:  Fabian den Brave; Arushi Gupta; Thomas Becker
Journal:  Front Cell Dev Biol       Date:  2021-12-03

Review 5.  Quality control of cytoplasmic proteins inside the nucleus.

Authors:  Lion Borgert; Swadha Mishra; Fabian den Brave
Journal:  Comput Struct Biotechnol J       Date:  2022-08-23       Impact factor: 6.155

Review 6.  Out of Control: The Role of the Ubiquitin Proteasome System in Skeletal Muscle during Inflammation.

Authors:  Stefanie Haberecht-Müller; Elke Krüger; Jens Fielitz
Journal:  Biomolecules       Date:  2021-09-08

7.  An Arsenite Relay between PSMD14 and AIRAP Enables Revival of Proteasomal DUB Activity.

Authors:  Sigalit Sukenik; Ilana Braunstein; Ariel Stanhill
Journal:  Biomolecules       Date:  2021-09-06

8.  Oxaliplatin promotes siMAD2L2‑induced apoptosis in colon cancer cells.

Authors:  Lu Ma; Xin Li; Xiaopeng Zhao; Haotong Sun; Feifei Kong; Yuanjie Li; Yu Sui; Fang Xu
Journal:  Mol Med Rep       Date:  2021-07-19       Impact factor: 2.952

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.